Umbilical cord‑derived mesenchymal stem cells.pdf

Umbilical cord‑derived mesenchymal stem cells (UC‑MSCs) are ethically sourced from Wharton’s Jelly and offer robust regenerative and immunomodulatory effects with minimal rejection risk. Their youthful biology makes them highly promising across treatments—from inflammatory conditions and aging to metabolic disorders.

1. UMBILICAL CORD-DERIVED
MESENCHYMAL STEM CELLS (UC-MSCS):
SHAPING REGENERATIVE MEDICINE
Umbilical cord-derived mesenchymal stem cells (UC-MSCs)
are ethically sourced from Wharton’s Jelly and offer robust
regenerative and immunomodulatory effects with minimal
rejection risk. Their youthful biology makes them highly
promising across treatments—from inflammatory conditions
and aging to metabolic disorders.
What Are UC-MSCs?
Perks of UC-MSCs
Therapeutic Properties Clinical Applications
Mesenchymal stem cells extracted
from Wharton’s Jelly
Higher regenerative potential than
other MSC sources
Ethical and non-invasive collection
Called Age 0 cells
Low immunogenicity
High proliferation & differentiation capacity
Abundant source
Safe and non-controversial origin
Tissue regeneration
Anti-inflammatory effects
Immunomodulation
Angiogenesis
Anti-fibrotic
Ongoing Research
Pathways of UC-MSCs therapeutic effects
Long-term and large-scale clinical studies
Improving UC-MSCs therapeutic potential
Creating 3D cell constructs
Redefining therapies with premium quality
Umbilical cord-derived mesenchymal
stem cells (UC-MSCs) from Kosheeka.
Neurological disorders (e.g., Autism, Stroke, MND)
Orthopedic injuries (e.g., Osteoarthritis)
Autoimmune diseases (e.g., MS, Lupus)
Skin rejuvenation & anti-aging
Hair loss treatments
Diabetes & wound healing